CPT Capital is a London-based family office venture investor backing companies globally, with activity across the United States, Israel, Europe, the United Kingdom and Asia. The firm focuses on alternative protein, food technology, biotechnology and materials innovation, including plant-based, biomass fermentation, recombinant protein and cultivated meat solutions that replace animals in food and supply chains. It primarily targets pre-seed, seed and early-stage companies developing science-led food and sustainability technologies.